Antihypertensive dose-response relationships studies selective alpha agent terazosin Terazosin selective alpha agent treatment hypertension aim multicenter study patients mild essential hypertension characteristics terazosin range mg daily Patients active treatment groups group months treatment doses terazosin period conventional office measurements supine diastolic blood pressure automated ambulatory blood pressure monitoring clear antihypertensive dose-response relationship terazosin range mg mg dose none doses mg mg additional efficacy office measurements monitoring data ratio trough effect end interval maximum effect interval treatment mg dose mg meaningful clinical antihypertensive efficacy effects full period 